Newamsterdam Pharma Company

NAMSNASDAQ · US

Holders

DISCLOSEDQuarterly
Duquesne Family Office
Newamsterdam Pharma Company · NASDAQ
3,070,146 sh · $104.0M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Viking Global Investors
Newamsterdam Pharma Company · NASDAQ
4,203,567 sh · $142.5M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Viking Global Investors
Newamsterdam Pharma Company · NASDAQ
4,203,567 sh · $134.6M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Duquesne Family Office
Newamsterdam Pharma Company · NASDAQ
3,070,146 sh · $98.3M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Newamsterdam Pharma Company · NASDAQ
4,203,567 sh · $147.5M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Duquesne Family Office
Newamsterdam Pharma Company · NASDAQ
3,070,146 sh · $107.7M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Polen Capital Management
Newamsterdam Pharma Company · NASDAQ
11,239 sh · $394.3K
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Duquesne Family Office
Newamsterdam Pharma Company · NASDAQ
1,923,700 sh · $54.7M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Newamsterdam Pharma Company · NASDAQ
6,475,534 sh · $184.2M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Duquesne Family Office
Newamsterdam Pharma Company · NASDAQ
832,175 sh · $15.1M
Filed 30 Jun 2025SEC 13Fview source